ࡱ> (G s d   "PowerPoint.Show.80BMicrosoft PowerPoint Presentation Backhttp://www.chromatherapeutics.com/Cell-Accumulation-Approach.htmb/ 0DTimes(p(0(z[ 0  DArial(p(0(z[ 0  A .  @n?" dd@  @@`` @ 8  TV      %'B%'FB 6M*) +*,&- K" L4"dRaVF &>'5++"dJ-C!R"" #N- &   EE ## !'+C7W#// 0AA 33f@ g4BdBd@z[ 0.pp<4!d!dl 0p<4BdBdl 0pg4PdPd@z[ 0p$ pJo ʚ;S:ʚ;<4ddddl|- 0X0___PPT10 ppR___PPT94/ 0 ?, CONFIDENTIALO =*ESM technology: enhancing drug performance++* *ESM technology: enhancing drug performance++* *ESM technology: enhancing drug performance++*  Back   U 0  ` ̙33` ` ff3333f` 333MMM` f` f` 3>?" ddb~?" duld2b 1" b +\ n?" dd@   @@``PR  1 b  ` p>>   h@(  h h TԮyy O)  X Click to edit Master title style!!  8 h Ntyy k"  RClick to edit Master text styles Second level Third level Fourth level Fifth level!    S   h Nxyy Fv  x*  b11bb h Nldzyy F#v   r*   b11bb h Nʳyy Fv  r*   b11bb  h L ?? Base"8 H h 0&Ón ? ̙334,___PPT10 . (1_Blank PresentationL 0 \( ~^   Ne aa .7    ~*     ;;;XXvv  NDw aa e 7   *     ;;;XXvvd  c $ ?8[   8  Ny aa  6]u   RClick to edit Master text styles Second level Third level Fourth level Fifth level!    S    T aa .G    ~*     ;;;XXvv  T aa e G   *     ;;;XXvvH  0af ? ̙3380___PPT10.0oO ((    N aa .7    \* ;;;XXvv  ND aa d 7   ^* ;;;XXvv  Tذ aa .F    \* ;;;XXvv  Tl aa d F   ^* ;;;XXvvH  0af ? 3380___PPT10.Ӑ5(* K0 &&c(     B3CBDE`Fd @XX^p=# 8`  #El.>Uk!* 08?B?BM?[;j9570,  1X}kk_TH9+),31/$ f%wO-"ug`lVlV/+@+|G<%% !^^>@@                             `" `cx  c $h?D   nF "\ _     2  Zvd @" g\  2  Zd @" `9 ?2  Zvd @" `" } 2  Zvd @" `g_2   Zvd @" ` 2   Zvd @"  F !   0\SF?3,$ 0 - Neutral molecules pass freely through cell( 2.-    0| " S  jIntracellular target 2    0  td  x" Parent molecule 2 (  0l F?Y ,$ 0 6 Pharmacokinetics limited by clearance from plasma&%76 nF "\ _   2  Zvd @" g\  2  Zd @" `9 ?2  Zvd @" `" } 2  Zvd @" `g_2  Zvd @" ` nF "\ _   2  Zvd @" g\  2  Zd @" `9 ?2  Zvd @" `" } 2  Zvd @" `g_2  Zvd @" ` nF "\ _   "  2  Zvd @" g\  2  Zd @" `9 ?2  Zvd @" `" } 2  Zvd @" `g_2   Zvd @" ` nF "\ _ ! V p e Y 2 " Zvd @" g\  2 # Zd @" `9 ?2 $ Zvd @" `" } 2 % Zvd @" `g_2 & Zvd @" ` H  0&Ón ? ̙33___PPT10.=+hD' = @B D' = @BA?%,( < +O%,( < +D ' =%(%(D'' =%(D' =A@BBBB0B%())))?D' =1:Bhidden*o3>+B#style.visibility<* %(D' =%(DZ' =A@BBB B0B%(D' =1:Bvisible*o3>+B#style.visibility<* %(D' =-6B-randombar(horizontal)*<3<* DF' =%(D' =4@BB?BB%()?)?)?)@D"' =.7 BBBBB'M 0 0 L 0.25 0 E*3>*B ppt_xB ppt_y=0BB<* D' =%('DZ' =A@BBB B0B%(D' =1:Bvisible*o3>+B#style.visibility<*%(D' =-6B-randombar(horizontal)*<3<*Dr' =%()D' =4@BB@BB%()?)?E<' =1B B`BPB1:Bhidden*3>+B#style.visibility= `B<* %(D*' =.7 BBBBB/M 0 0 L 0 -0.33313 E*3>*B ppt_xB ppt_y=0BB<* ++0+   ++0+   ++0+  +-  K0 ** o(       B3CBDE`Fd @XX^p=# 8`  #El.>Uk!* 08?B?BM?[;j9570,  1X}kk_TH9+),31/$ f%wO-"ug`lVlV/+@+|G<%% !^^>@@                             `" `cx   c $h?D   nF "\ _      2   Zvd @" g\  2   Zd @" `9 ?2   Zvd @" `" } 2   Zvd @" `g_2   Zvd @" ` z        ,$D  02   Zvd @"    R   Zvd @"  9Y R    `3vd @" `Y 9 N   S  S    0& ! R  jIntracellular target 2    0|&SF?3,$ 0 + Linking motif to parent creates novel IP( 2,+    0&F?,$ 0 * Neutral parent/motif is cell permeable&+* 2   Zvd @"  F ,$D 0nF "\ _    2   Zvd @" g\  2   Zd @" `9 ?2   Zvd @" `" } 2   Zvd @" `g_2   Zvd @" ` nF "\ _    2   Zvd @" g\  2   Zd @" `9 ?2   Zvd @" `" } 2   Zvd @" `g_2   Zvd @" ` nF "\ _    "  2   Zvd @" g\  2 !  Zd @" `9 ?2 "  Zvd @" `" } 2 #  Zvd @" `g_2 $  Zvd @" ` nF "\ _ %  V p e Y 2 &  Zvd @" g\  2 '  Zd @" `9 ?2 (  Zvd @" `" } 2 )  Zvd @" `g_2 *  Zvd @" ` H   0&Ón ?     ̙33jb___PPT10B.=+uD' = @B Da' = @BA?%,( < +O%,( < +D' =%(%(D' =%(D}' =4@BBB B%()))D' =1:Bvisible*o3>+B#style.visibility<* %(D' =-6B-randombar(horizontal)*<3<* D' =%(DZ' =A@BBB B0B%(D' =1:Bvisible*o3>+B#style.visibility<* %(D' =-6B-randombar(horizontal)*<3<* D' =%(Dg' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<* %(D' =-s6Bwipe(down)*<3<* D' =%( DZ' =A@BBB B0B%(D' =1:Bvisible*o3>+B#style.visibility<* %(D' =-6B-randombar(horizontal)*<3<* D' =%(|D' =4@BBBB%(D' =1:Bhidden*o3>+B#style.visibility<* %(D&' =%(|D' =4@BB?BB%()?)?D"' =.7 BBBBB'M 0 0 L 0.25 0 E*3>*B ppt_xB ppt_y=0BB<* +p+0+ & ++0+ & +P K0 ++AB$<+(  $ $  B3CBDE`Fd @XX^p=# 8`  #El.>Uk!* 08?B?BM?[;j9570,  1X}kk_TH9+),31/$ f%wO-"ug`lVlV/+@+|G<%% !^^>@@                             `" `cx $ c $&h?D  & R $ Zvd @" ` iY nF "\ _ $    2 $ Zvd @" g\  2 $ Zd @" `9 ?2 $ Zvd @" `" } 2  $ Zvd @" `g_2  $ Zvd @" ` F Y |   $ Y  2  $ Zvd @" ` | R  $  `3vd @" `Y . N $ S   S  $ 0 & ! R  jIntracellular target 2 5 $ 0& F ,$ 0 C Motif cleaved by intracellular enzyme leaving charged species&1DC nF "\ _ $  2 $ Zvd @" g\  2 $ Zd @" `9 ?2 $ Zvd @" `" } 2 $ Zvd @" `g_2 $ Zvd @" ` nF "\ _ $  2 $ Zvd @" g\  2 $ Zd @" `9 ?2 $ Zvd @" `" } 2 $ Zvd @" `g_2 $ Zvd @" `  $ 0$&L F?,,$ 0 ) Charged species also novel/patentable&*) nF "\ _ $  "  2 $ Zvd @" g\  2  $ Zd @" `9 ?2 !$ Zvd @" `" } 2 "$ Zvd @" `g_2 #$ Zvd @" ` nF "\ _ $$ V p e Y 2 %$ Zvd @" g\  2 &$ Zd @" `9 ?2 '$ Zvd @" `" } 2 ($ Zvd @" `g_2 )$ Zvd @" `  *$ Zv @" `,  ,$D 0 +$ 0h&F?,$ 0 & Charged species accumulates in cell&'&  ,$ 0&SF?3 + Linking motif to parent creates novel IP( 2,+  -$ 0&F? * Neutral parent/motif is cell permeable&+*  /Y   .$# MM ,$D 02 /$  `vd @" `  R 0$  f3vd @" `/Y   /Y   1$# / }} /,$D  02 2$  `vd @" `  R 3$  f3vd @" `/Y   /Y   4$# \ S S \ ,$D  02 5$  `vd @" `  R 6$  f3vd @" `/Y   /Y   7$#  ,$D  02 8$  `vd @" `  R 9$  f3vd @" `/Y   /Y   :$# S S ,$D  02 ;$  `vd @" `  R <$  f3vd @" `/Y  z   =$  ,$D  0n >$ 0"`L 6 ?$ 0X "`R j N Family of three enzymes Expression of one is restricted to macrophages:  2%ON ZB @$B s *D =L  A$ 0) "`( Y ,$ 0 =  2' H $ 0&Ón ?  $ $$ ̙33$$___PPT10h$.=++D\#' = @B D#' = @BA?%,( < +O%,( < +DN"' =%(%(D' =%(DZ' =A@BBB B0B%(D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =-6B-randombar(horizontal)*<3<*$D' =%(D3' =4@BB BB%(D' =1:Bvisible*o3>+B#style.visibility<**$%(D' =-o6Bdissolve*<3<**$D' =%( Ds' =4@BB8BB%()?)?E<' =1B B`BPB1:Bhidden*3>+B#style.visibility= `B<*$%( D' =.K7 BBBBB]M -2.03445E-6 3.65544E-6 L -0.27629 -0.28269 *3>*B ppt_xB ppt_y=@0BBAApBB'v B<*$D@' =A@BB BB0B%(D' =1:Bvisible*o3>+B#style.visibility<*A$%(D' =-o6Bdissolve*<3<*A$D' =%(DZ' =A@BBB B0B%(D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =-6B-randombar(horizontal)*<3<*$D' =%(XDZ' =A@BBB B0B%(D' =1:Bvisible*o3>+B#style.visibility<*+$%(D' =-6B-randombar(horizontal)*<3<*+$D' =%((#D3' =4@BB BB%(D' =1:Bvisible*o3>+B#style.visibility<*.$%(D' =-o6Bdissolve*<3<*.$D' =%()D3' =4@BB BB%(D' =1:Bvisible*o3>+B#style.visibility<*:$%(D' =-o6Bdissolve*<3<*:$D' =%(,D3' =4@BB BB%(D' =1:Bvisible*o3>+B#style.visibility<*7$%(D' =-o6Bdissolve*<3<*7$D' =%(0D3' =4@BB BB%(D' =1:Bvisible*o3>+B#style.visibility<*4$%(D' =-o6Bdissolve*<3<*4$D' =%(4D3' =4@BB BB%(D' =1:Bvisible*o3>+B#style.visibility<*1$%(D' =-o6Bdissolve*<3<*1$D' =%(8D0' =4@BBBB%(D' =0l9 HCHCBB*<3<**$D' =%(t@D3' =4@BBBB%(D' =1:Bvisible*o3>+B#style.visibility<*=$%(D' =-o6Bwipe(up)*<3<*=$++0+$  ++0+$  ++0++$  ++0+A$  +  T(  Tr T S hfF9   H T 0&Ón ? ̙3380___PPT10.6N!x= tՑ#͡cFmm[>CFo.;N #vfl0 A&@0d Gn8C6aMYHbHZLOhFQ~Wկ_wϕ848BC @;IYBgѧ/6GAbrh4[̦ 1ll\їg]{iÏV?Wv!}g7KThLis5zlwhPjƢ|l9΂:,zĩP1Qȡ}7;ye4$l[bƜq9Q;_NvG)F(A(Es "  ! E0aHQ:h1c*!Gh0 a Tif P0al9s!G8aB ab%K!,GXp‰'!p JU"o`/C8 o"p·FXm PG8!Ј !pFB3CDu(Hq.J^DA8KGD:/ʴ1ch7ڧcV-t}eOC]AlQRVysV?^d}OHӠ̱ $KAXC`cKҏ x |odg\n6!wۅ<2!>%dqǗL>ΐASOGE.˭Oc /ctS4nׄᦖhE_84fS:Z-, ~ґ>N+`s GKg$o٨? pUz,P7lZ- zCd5i G1+Ï F V[bQh1Ac -@sk O6l1$Z~g|^7WH+K_'УqM­#PCCrW-h.3LrEyuUeH$Т 1G GZUz}Z}ޤp4W76%CK#)1gvMάIծ  [p8jU//Wkn9 U̟^"_>{meڿioxoD:N?ʺ)^@;W!?)/A5<S:K[#^ס,x·yRP9# ~Y-Sޅg?D=u-A(CQuwz6+@] fܞ=dn^}q%gC+c>ld|U@t^i^(r-bR^Ĭ>Dl8kyFHnʞ OMj1izSÔre*~ٞFs;LO8NcoHiQ~sjo9zzWTyL.ɖ^~"]EycSjVHD|V|]g%WLD:Tފ"/:\\oS둣J׬3e"IJd,m_gJ>sYOs?H:MX[]dJxx6w/f}*W'LNiHTʑGcpg.c),WK'~A]c)D^ǗODHO5ݟj6}XڜL{HTҮt-c9]nJ쯴VY `ݯ]DKz-u OYӵYțl89<~vYyWtnwhɐ%UO爴T^zz!i~w]Sϸ v)> v{ ,Sq(*:Ʈ6ڡS&*xg k<4<̇Ru0e@uXFT#S+w~ٹ {D1]YL."{ D[SJB2 ʓj0uTw:Lmd[/|#[/I9o  K)qsrNJrrX)j9^Nagy_Kåǘp,Cz*uQWb+b~*,D ڽ.rތwOK~n+pnAꡂ =Ok7HK}+‡[ >}$:ίdBF%Mp,S'w _ gmVށInӼP&pS$m/ɮ힎XX4c*41z{Gc[Oc?ިvsA HW=w7::௃xTNO T+,\DGK- z(9*YMX6s8JX{ :ع#ο)W`_>O=*\fiS?.9;tF۽wkO_>5=lT=@ w#@+z.Z==/ |)ˋ//c]M YҖ/|a3'qfGBw_/wʜSCT5;/;%wF3QFIr N`N"jG_4hB3[4hN4/1g>B؈kD$Je@[餲\DSMc>18ǸcyEKq Kq)'>9oeKӜstG-s}7ĥS2ɛ˛PF(ǩǩgjgjSQMCs~ypK -#oi^C^mCܩGT28?(. )!7Ԫ i~^]'ݸUhNF ,z7#ۊf.48ݨQ(p>$ 5fOv?[JF_\U0$>B]8,Í# ƧrK=R8̣M06[qy)R©5W~,sr]7 zT¿~$ ;1" \9ierG4@݀G[>u qm/X"Ow5!%e^J_ֱ[[QSHi :}tx p:.Z/-i}{)O?5)p(PVctꍑ@ E5E›64P;r.@caY|+31J< PC`bKF00^ڒ""4D>' DЦ? &_H1;r  eE%)ݡhdqLy_k(r)lthK#t!7fۈ`o%}eM4vi }.$>˝hD4L!&_l Ă$١`s0hݢׇ`vc$ܬf?i|O|z2. _9ތl}6w l cPns`ܴnPFA[Λf\*luClu\qQ*(zLpkkHk(kǵntF;Z(9cz͵n͵Z7Z7vZgzE(M/Efx>?(=׭xZEc_i`Yؔߎi>Oa4z]HY!*T Jl}q@0L`S :xD xaA_Wetu2.!]JHW,G+7c-3*$vڝvѮ8mW[1vNyAEzb WƆIm2?t]`G[-H%L3y9CH0 3:nc7wRB5A/>ax #ð;%ITB ei"BoŬ/&]|-ʯeӭY\WoXA i}FAZ\$B*bI-*3wNv'ieSK_ ;(܂~?OjU$u#i-^C3M }3*$ޘ]ֱ"ϒ^K.OKo]$Vkmɶ6ٶ"eLZ̶Ni9VSK8ȃ_SNymtXΦ5+x_ͪV %lpZ ]8YƛL&b J<&iʷM跃_,RFTB:&q ͱ^k;z sFab ݨHuƋ5FIdemeQ' ,\ā)㲬cr7NJ IڱBlĨa3lZ+4!ڻ4;sZw-%E*?xpf`FlZs8lMH%Vj'(-@&[X* 6 7,M˔2Gwcopu7v[6#Vι3s+ՉO(CP@}9zY* h/";ul nPxXqhs'q͝6w+l$Qb\\\F\FqQbukhkkXk]e׺q*vx͵n͵n͵n͵n;c!QPЮ3.?N bHKNtW,\6 1^1֫6K[ 1wc7UGcoĕ1~b/α^됓R9@WaYSYd7OE]yBmOLh#HPr}\0\IrwP,eZti 79 'Gׂ!>UδVD~"QD==lYoR-NF{$OJ*!Vr/tYZ`zz]6v9H/.;>϶I=SQq=9@U>`zuY=500@z#-@o T@U}wEwewwLS2PQu<# p^t;Tv'o~Y+K՛w/՛O/}!%UvዊЋ2jY qMѺ,cjzg󺁚`J;kKOs[kWv'XF;؆n.ZWQBz\뎱 9ڇ);bڮ44Gކ+ٝdG^(KG}Y`{cqR+݁Ď.dPGhG067Lmn0aM*3jU8kxkkDk$iߙ*"*۴"_Xs%|gD-wyٙKn΢\qm,%gl]ɵ$6䩘]tj7f`Ki5҇A}ͧ5T";ϔ5Gߖ6<5c|m$ 1N˪ibd\ݓ?rrٙJ+pI%iYEL/%7;!^-,G,A.ge= ,zxzŮ=3DS vq>OpQ3k֖/ɶ2>óE_~TY9NÞ =Srr }u ]+tQ ZSmh}³6޳N$ yVKw3.$"7C[p#2rW8Z~Ak$-xo[c^,0$Hɿ]ӮFR/$#MO'KhzDL!`Q|0 ~8l'?f]obe+uS(<j\D xY]l>h[Tq4qӔCR,'QctvF2`nY)PT K҇= X1,]e?MaX1`{mͶ C (hߥHKv|{Ͻt{t3ەVjqwR0=O&~6yNA9/W?; [ vh31 z lsIiw3g~wԨϸdbqj U}֏_6mFZl.5] +fہǀ<tN`<z $@W> 1`qb{[CW']gH?C ]EbI-T)D4֢f4gī8jb2OUfi5-u԰9s^3󅴝3J+<VEXmt(1/:q5ޥDVZ_E@ِJp?dI) $ _6ag*XXIF#RHK H!YR $)!i,I}sů$cR/x"GTzDYz@_+a[*͑j;e=I{yTh7λ< ^2wjq>2 D 78n.6? nVÞq70~oUZ':M|M5Ng-Y墝5gmT0 U$_$ީT)BL4 vIP\+uKԭ:vHƎMLm2aejb]Qn򋉒mo FtWuqlv6[e(*sANySe$S$I-ԧ%Y }e=(krS^~ㄕ΋) <ːeY[^us:rKFQLB~s7 Ś?Zy0#x8#C dH&=Dm4`ߪ<(T7z?g &cΉnEgLBV^fsYoF$]8 O' +]0Jv.S_fN3̦vއi[oUz#Ͼι/xPm>A&U*ο~4VX`]RjwP  a-MݷTٽ^/ y">h8RW"1a1W'}8m8^pl Ս~,nvR]ANrX+Vf'.3ʊJl,S$)*Μ5 p^z_r$_*~skO2ӻQ}t?YnEYmJ ۶r3%ģt؅C,tkrsX'y~ݕPմ ^ W,>I(Y+V?h>Ĵ;Xo9fT(zuSmp/F1c VN7 qɓ<ɓD~{w[`qI8a'0y'2y2- Y|w qVr@s%0 +ӲӸٸmٸӸٸٸٲӲٸӸӸٲӲӸӸٸӸٸӲӸӸٸٸٸӲӲӸӸٸٸӸӸJӸӸٸٸٸٸӸӸٸٸٸٸٲmӸӸٸӸӸٸBٸٸٸٲӸmӸٸٸӸٸӸٸٸٸٸӸٸӸӲmӸٸӸӸٲٲӸCٸٸٸٸٸٸӸӸӸCCٸٸӸٸӸӸӸٸٸӸӸٸӸӸӸٸӸٲٸӸٸӸӸٸӸӸٲӸٲӸӸӸӸӲӸٸӸٲٸӸٲӲٲٲӸӸӸӲӸӸٸӲٸӸӲӲӸӲӸӸӸӸӸӸӲӲٲӸDӲӸӲӸӸӲӲӸCDӲB՜.+,D՜.+,    CustomJohnson Empire"A TimesArial1_Blank Presentation"Microsoft PowerPoint Presentation+ESM technology: enhancing drug performance+ESM technology: enhancing drug performance+ESM technology: enhancing drug performanceSlide 4  Fonts UsedDesign TemplateEmbedded OLE Servers Slide Titles 8@ _PID_HLINKSAAhttp://www.chromatherapeutics.com/Cell-Accumulation-Approach.htm_CharlesCharles  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root EntrydO)Current UserSummaryInformation(DUPowerPoint Document(DocumentSummaryInformation8